Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2001-6-14
pubmed:abstractText
Physicians should be cautious in prescribing broad-spectrum antibiotics, particularly vancomycin and the fluoroquinolones, because widespread use of these drugs is promoting antibiotic resistance. Resistance is now found in many organisms, including staphylococci, enterococci, streptococci, pneumococci, and Pseudomonas aeruginosa. Some resistant strains can be treated with alternative narrower-spectrum antibiotics. In addition, five newly licensed antibiotics are available, but they should be used judiciously because of their side effects, high cost, and ability to promote additional resistance.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Acetamides, http://linkedlifedata.com/resource/pubmed/chemical/Anti-Infective Agents, http://linkedlifedata.com/resource/pubmed/chemical/Atovaquone, http://linkedlifedata.com/resource/pubmed/chemical/Aza Compounds, http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations, http://linkedlifedata.com/resource/pubmed/chemical/Fluoroquinolones, http://linkedlifedata.com/resource/pubmed/chemical/Naphthoquinones, http://linkedlifedata.com/resource/pubmed/chemical/Oxazolidinones, http://linkedlifedata.com/resource/pubmed/chemical/Proguanil, http://linkedlifedata.com/resource/pubmed/chemical/Quinolines, http://linkedlifedata.com/resource/pubmed/chemical/Vancomycin, http://linkedlifedata.com/resource/pubmed/chemical/Virginiamycin, http://linkedlifedata.com/resource/pubmed/chemical/gatifloxacin, http://linkedlifedata.com/resource/pubmed/chemical/linezolid, http://linkedlifedata.com/resource/pubmed/chemical/malarone, http://linkedlifedata.com/resource/pubmed/chemical/moxifloxacin, http://linkedlifedata.com/resource/pubmed/chemical/quinupristin-dalfopristin
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0891-1150
pubmed:author
pubmed:issnType
Print
pubmed:volume
68
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
496-7, 501-2, 504
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:11405611-Acetamides, pubmed-meshheading:11405611-Anti-Infective Agents, pubmed-meshheading:11405611-Atovaquone, pubmed-meshheading:11405611-Aza Compounds, pubmed-meshheading:11405611-Drug Combinations, pubmed-meshheading:11405611-Drug Resistance, Microbial, pubmed-meshheading:11405611-Drug Therapy, Combination, pubmed-meshheading:11405611-Enterococcus, pubmed-meshheading:11405611-Fluoroquinolones, pubmed-meshheading:11405611-Humans, pubmed-meshheading:11405611-Methicillin Resistance, pubmed-meshheading:11405611-Naphthoquinones, pubmed-meshheading:11405611-Oxazolidinones, pubmed-meshheading:11405611-Proguanil, pubmed-meshheading:11405611-Pseudomonas aeruginosa, pubmed-meshheading:11405611-Quinolines, pubmed-meshheading:11405611-Staphylococcus aureus, pubmed-meshheading:11405611-Streptococcus pneumoniae, pubmed-meshheading:11405611-Vancomycin, pubmed-meshheading:11405611-Vancomycin Resistance, pubmed-meshheading:11405611-Virginiamycin
pubmed:year
2001
pubmed:articleTitle
Microbial drug resistance and the roles of the new antibiotics.
pubmed:affiliation
Department of Infectious Diseases, Cleveland Clinic Foundation, OH 44195, USA. longwod@ccf.org
pubmed:publicationType
Journal Article, Review